AnderMed, a medical device manufacturer, has achieved rapid growth by prioritizing innovation. The company developed umbilical arteriovenous catheters for babies, facilitating medication administration through the umbilical cord and reducing needle discomfort. AnderMed is the first in China to produce such a solution.
The company allocates 5 percent of its annual sales revenue to research and development, a strategy that has significantly contributed to its growth. Currently, the company holds over 150 patents and has played a significant role in the development of nearly 50 national and industry standards. Its products serve approximately 4,000 hospitals.
In the future, Zibo will boost innovation in key fields, including artificial intelligence and new materials, bolster the in-depth integration of cutting-edge digital technologies with the real economy and strengthen the training of high-quality and digital-savvy talent.
An automatic production line at a factory belonging to AnderMed. [Photo by Liu Chuan/chinadaily.com.cn]
